Healthcare Industry News:  obstructive sleep apnea 

Devices Personnel

 News Release - June 14, 2007

XLTEK Announces New Senior Management Appointment

OAKVILLE, ONTARIO--(Healthcare Sales & Marketing Network)--Jun 14, 2007 -- Excel-Tech Ltd. ("XLTEK") (Toronto:NRV.TO ) a medical technology company that designs, develops and sells proprietary neurodiagnostic and sleep therapy devices, announced today that Mr. Steven Plymale has been appointed Vice President, Quality and Customer Care.

Mr. Plymale has over 18 years of experience in the medical device market. Most recently, Steve was Director of Product Support with CryoCath Technologies Inc. where his objective was to achieve and maintain a high level of customer satisfaction. Prior to that, Steve was Director of Quality for CryoCath. Steve had previously held various managerial level roles with Cedara Software from 1989 to 2000.

"We are pleased to appoint Steve to this new position. XLTEK continues to focus its attention on improving customer satisfaction and generating increased recurring revenues from our advanced neuro-diagnostic instruments which are installed in over 1,300 hospitals. We believe that Steve, by focusing on increasing XLTEK's customer satisfaction levels within these leading hospitals, will directly and positively impact the development of the warranty, preventative maintenance and disposable accessory offerings that are cornerstones of our growth strategy." commented John Mumford, President and CEO.


Excel-Tech Ltd. ("XLTEK") is a medical technology company that designs, develops and sells proprietary neurodiagnostic and sleep therapy devices. XLTEK's Advanced Neuro-Diagnostic Instruments are used by neurology specialists at leading hospitals in the US to assist in the diagnosis and monitoring of epilepsy, peripheral nerve and sleep disorders and the monitoring of the nervous system during surgery. XLTEK's new SleepRite continuous positive airway pressure device measures both the compliance and the effectiveness of therapy for patients with obstructive sleep apnea. XLTEK is headquartered in Oakville, Ontario, Canada. The Company's common shares trade on the Toronto Stock Exchange (Symbol: NRV.TO). Additional information about XLTEK and its products may be found at

Forward-Looking Statements:

Certain statements contained in this release containing words like "believe", "intend", "may", "expect" and other similar expressions, are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the Company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain and develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products and other risk factors identified from time to time in the Company's filings.

Source: Excel-Tech

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.